NEW YORK, Dec. 18, 2012 — We were shocked and deeply saddened by the events that took place at the Sandy Hook Elementary School in Newtown, CT on December 14, 2012. We cannot comprehend the losses suffered by the families and friends of those killed by the unthinkable crimes committed that day. No words or … Read more
Cerberus Capital Management Statement Regarding Freedom Group, Inc.
Cerberus Completes Sale of Guilford Mills
NEW YORK, June 7, 2012 – An affiliate of Cerberus Capital Management, L.P., one of the world’s leading private investment firms, has completed the sale of Guilford Mills, a global leader in automotive and specialty fabrics, to Lear Corporation, a leading global supplier of automotive seating and electrical power management systems, for a total purchase price … Read more
Cerberus Acquires Speymill Deutsche Immobilien Assets out of Receivership
FRANKFURT and LONDON, 16 May, 2012 – An affiliate of Cerberus Capital Management, L.P. (“Cerberus”) has entered into a definitive agreement to acquire the assets of distressed company, Speymill Deutsche Immobilien Company plc, from the Receivers. As a key part of this transaction, Cerberus worked with the company’s bank lenders to effect the recapitalization of … Read more
YP Launches Today as North America’s Leading Local Search, Media and Advertising Company
Former AT&T Advertising Solutions and AT&T Interactive units combine industry-leading assets to form standalone unit under YP Holdings Cerberus Capital Management acquires controlling interest TUCKER, GA, May 9, 2012 -– YP Holdings LLC (“YP”), which combines the assets of AT&T Advertising Solutions and AT&T Interactive into North America’s largest local search, media and advertising company, … Read more
Cerberus Business Finance Prices $833 Million CLO
NEW YORK, April 17, 2012 – In the largest broadly syndicated or middle market CLO closed this year, Cerberus Business Finance LLC announced today that it has priced an $833 million CLO, A5 Funding L.P. which will support Cerberus’ middle-market loan origination platform. The transaction is expected to close on Friday, April 27, 2012. Natixis … Read more
Robert L. Nardelli Transitions to Senior Advisor to Cerberus Capital Management, L.P.
NEW YORK, March 9, 2012 – Cerberus Capital Management, L.P. (“Cerberus”) and Robert L. Nardelli today announced that Nardelli has transitioned to a role as Senior Advisor to Stephen A. Feinberg, CEO of Cerberus, and that Chan W. Galbato, a long-time Nardelli protégé, has succeeded Nardelli as the CEO of Cerberus Operations and Advisory Company, … Read more
Covis Pharma to Acquire U.S. Rights from GlaxoSmithKline for Fortaz®, Zinacef®, Lanoxin®, Parnate®, and Zantac® Injection
ZUG, Switzerland, December 22, 2011 – Covis Pharma Sarl (“Covis Pharma”), a Switzerland-based specialty pharmaceutical company owned by affiliates of Cerberus Capital Management, L.P., today announced an agreement with GlaxoSmithKline to acquire full commercial rights for Fortaz(R) (ceftazidime), Zinacef(R) (cefuroxime), Lanoxin(R) (digoxin), Parnate(R) (tranylcypromine sulfate), and Zantac(R) Injection (ranitidine hydrochloride) in the United States and … Read more
Cerberus Hires Allen Ukritnukun as Head of European Corporate Distressed Trading and Investing
NEW YORK and LONDON, December 20, 2011 – Cerberus Capital Management, L.P. (“Cerberus”) today announced that Allen Ukritnukun has joined the Firm as head of European Corporate Distressed Trading and Investing. Mr. Ukritnukun will be based in London and will manage a team focused on European and Asian distressed investing, including financials, sovereign debt and … Read more